The many faces of PPARγ: anti-inflammatory by any means?

A Szanto, L Nagy - Immunobiology, 2008 - Elsevier
The peroxisome proliferator-activated receptor γ (PPARγ) is a member of the nuclear
receptor superfamily, a group of transcription factors that regulate expression of their target …

Perspectives on precision cut lung slices—powerful tools for investigation of mechanisms and therapeutic targets in lung diseases

M Lam, E Lamanna, L Organ, C Donovan… - Frontiers in …, 2023 - frontiersin.org
Precision cut lung slices (PCLS) have emerged as powerful experimental tools for
respiratory research. Pioneering studies using mouse PCLS to visualize intrapulmonary …

Nrf2-regulated PPARγ expression is critical to protection against acute lung injury in mice

HY Cho, W Gladwell, X Wang, B Chorley… - American journal of …, 2010 - atsjournals.org
Rationale: The NF-E2 related factor 2 (Nrf2)–antioxidant response element (ARE) pathway
is essential for protection against oxidative injury and inflammation including hyperoxia …

Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease

MG Belvisi, JA Mitchell - British journal of pharmacology, 2009 - Wiley Online Library
Peroxisome proliferator‐activated receptors (PPARs) are ligand‐activated transcription
factors that belong to the nuclear hormone receptor superfamily. PPARγ regulates several …

The role of PPARs in lung fibrosis

HF Lakatos, TH Thatcher, RM Kottmann… - PPAR …, 2007 - Wiley Online Library
Pulmonary fibrosis is a group of disorders characterized by accumulation of scar tissue in
the lung interstitium, resulting in loss of alveolar function, destruction of normal lung …

Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?

J Becker, C Delayre‐Orthez… - Fundamental & clinical …, 2006 - Wiley Online Library
Lung inflammatory diseases, such as acute lung injury (ALI), asthma, chronic obstructive
pulmonary disease (COPD) and lung fibrosis, represent a major health problem worldwide …

PPARs: key regulators of airway inflammation and potential therapeutic targets in asthma

A Banno, AT Reddy, SP Lakshmi… - Nuclear receptor …, 2017 - pmc.ncbi.nlm.nih.gov
Asthma affects approximately 300 million people worldwide, significantly impacting quality of
life and healthcare costs. While current therapies are effective in controlling many patients' …

Sirtuin 1 promotes Th2 responses and airway allergy by repressing peroxisome proliferator-activated receptor-γ activity in dendritic cells

A Legutko, T Marichal, L Fiévez, D Bedoret… - The Journal of …, 2011 - journals.aai.org
Sirtuins are a unique class of NAD+-dependent deacetylases that regulate diverse
biological functions such as aging, metabolism, and stress resistance. Recently, it has been …

Peroxisome proliferator-activated receptors as novel targets in lung disease

MG Belvisi, DJ Hele - Chest, 2008 - Elsevier
Inflammatory diseases of the lung such as asthma and COPD represent a major worldwide
health problem. There are potent antiinflammatory drugs available to treat asthma, such as …

Airway epithelial cell PPARγ modulates cigarette smoke-induced chemokine expression and emphysema susceptibility in mice

SK Solleti, DM Simon, S Srisuma… - … of Physiology-Lung …, 2015 - journals.physiology.org
Chronic obstructive pulmonary disease (COPD) is a highly prevalent, chronic inflammatory
lung disease with limited existing therapeutic options. While modulation of peroxisome …